Daysy: The Contraceptive That Isn’t
August 6th, 2018
Are you hoping to transition from the birth control pill to Daysy? This new blog post describes exactly how to do it! https://t.co/CnwodCjUGW
— DaysyUSA (@DaysyUSA) February 27, 2018
On social media, Switzerland-based Valley Electronics markets its $330 Daysy device and attendant DaysyView app as a contraceptive, hormone-free alternative to using an IUD or the pill. But elsewhere, the company doesn’t seem so sure.
Case in point: After Chelsea Polis, a reproductive health epidemiologist, published a commentary in Reproductive Health in June that challenged the contraceptive effectiveness of Daysy, the company issued a statement that said Daysy is not a contraceptive per se:
… Daysy is not a contraceptive in the real sense. Daysy is a fertility tracker that uses the fertility awareness method (FAM) by tracking and analyzing the individual menstrual cycle.
Fast-forward to today, and over on the product’s website Valley Electronics contends that Daysy is not a contraceptive in any sense — real or make-believe:
Daysy is not a contraceptive. Daysy tells you when you are in your fertile window. During your fertile window, you can choose to use a contraceptive …
Why the mixed messaging?
“They’re manipulating people,” Polis said in an interview, “toying with their understanding of what contraceptive is and isn’t.”
Fertility awareness methods like Daysy use biomarkers (in Daysy’s case, body temperature) to identify fertile days on which to avoid unprotected sex, use protection or conceive. (Daysy lights up red on fertile days, green on infertile days, and yellow on days when it’s unsure.) But the effectiveness of these methods in planning for and/or preventing pregnancy is a matter of debate. And sometimes, they don’t work.
Polis’ commentary takes aim at the published analysis behind Valley Electronics’ claims that Daysy is 99.4 percent effective at “planning or preventing pregnancy.” The analysis, which is currently under editorial review following Polis’ request for retraction, looked at survey data from the 13 percent of registered Daysy users who responded to a questionnaire sent out in November 2016. One of the issues that Polis had with the survey itself was how it referred to an unintended pregnancy as an unwanted pregnancy, when an unintended pregnancy can be one that is wanted but mistimed.
But Polis said the analysis ultimately erred when it excluded from its calculations of contraceptive effectiveness women who had been using Daysy for fewer than 13 menstrual cycles. This was a group that not only comprised the vast majority of survey respondents but one that was arguably at greater risk of unintended pregnancy due to the fact that they were new to the method, Polis argues in the commentary.
“Women are believing them because there’s a study,” Polis said. But the study, she asserts in her commentary, is “fatally flawed.”
Niels van de Roemer, medical director for Valley Electronics and a co-author of the Daysy analysis, said in a statement to TINA.org that the company has “submitted a clarification” to Reproductive Health that addresses the concerns raised by Polis in her commentary.
The journal declined to comment, citing the ongoing review.
Check back for updates.